Shara Najimudeen
12 – 15 September, 2022, Virtual
Time Zone: Eastern Standard Time (EST) / UTC−05:00
The primary objective of PK/PD modeling is the prediction of the time course of the drug effect and its relation to dose and exposure. PK/PD represents and extremely useful tool for the selection of drug candidates, their optimization, and for maximal exploitation of early clinical studies for an optimal design of pivotal Phase 3 trials. This comprehensive and detailed PK/PD in Drug Discovery and Development online training describes the PK/PD studies from an industrial perspective to achieve a successful regulatory submission.
For pricing details, visit the website and request the agenda.
